- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
Patent holdings for IPC class A61K 31/7105
Total number of patents in this class: 4341
10-year publication summary
|
206
|
248
|
231
|
340
|
415
|
405
|
415
|
511
|
400
|
121
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Modernatx, Inc. | 1181 |
119 |
| Translate bio, Inc. | 394 |
69 |
| The Regents of the University of California | 18943 |
68 |
| The Johns Hopkins University | 5377 |
39 |
| Massachusetts Institute of Technology | 9795 |
38 |
| Alnylam Pharmaceuticals, Inc. | 1066 |
38 |
| Nitto Denko Corporation | 7879 |
37 |
| The Board of Regents of the University of Texas System | 2043 |
36 |
| Snipr Technologies Limited | 50 |
34 |
| The General Hospital Corporation | 4517 |
32 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
31 |
| Duke University | 2872 |
30 |
| Centre National de La Recherche Scientifique | 9632 |
29 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
26 |
| President and Fellows of Harvard College | 5792 |
25 |
| The Trustees of the University of Pennsylvania | 4122 |
25 |
| Osaka University | 3143 |
25 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
25 |
| University of Massachusetts | 2130 |
25 |
| BioNTech SE | 482 |
25 |
| Other owners | 3565 |